MAPK3 and melanoma: Markedly, Goetz et al. had shown in the past that overexpression of wild-type ERK1/2 and not the kinase-dead or low-kinase ERK1/2 variants in BRAFV600E mutant melanoma cell line A-375 leads to growth inhibitory effects88.